Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewExpanding analyst interest in ORYZON
New U.S. investment bank joins, bringing total coverage to ten analysts.
-
-
NewEHDS: A revolution in health data management
It aims to turn health data into a strategic asset to improve healthcare, accelerate innovation in health technologies and empower European patients.
-
NewAseBio leads a key Work Package in the european ShapingBio project to drive innovation in ...
AseBio has played a leading role as the head of Work Package 3, “Testing and Implementation,” one of the core pillars of the project.
-
New#NewAseBioMember | “For us, AseBio is a key platform for connection, visibility, and colla...
Meet Maieutics Research Solutions, our new member. We talk with Lander Ezequiel Senderowicz, Operational Manager
-
NewORYZON continues to strengthen its patent portfolio for vafidemstat
New “Decision to grant” communications in Canada and Israel. For the treatment of aggression and social withdrawal
-
NewMaria Terrades: "Scientific knowledge, cutting-edge research and entrepreneurial vision c...
In 2024, the Parc Científic de Barcelona (PCB) reached full occupancy of its facilities and is preparing for a forthcoming expansion with two key projects: the refurbishment of the CUB building, which
-
New86 AseBio members working on new solutions to tackle the challenges of the Green Transitio...
The report prepared by AseBio as an initiative of its Sustainability Committee identifies 587 solutions focused on identifying and adopting new ways of production and consumption that respect the
-
Press release86 AseBio members working on new solutions to tackle the challenges of the Green Transitio...
The report prepared by AseBio as an initiative of its Sustainability Committee identifies 587 solutions focused on identifying and adopting new ways of production and consumption that respect the
-
NewNatac, part of the European OliWa project to reuse olive tree biomass
The initiative focuses on the transformation of this biomass into animal feed, functional additives, environmentally friendly packaging, and biogas
-
CompanyMAIEUTICS RESEARCH SOLUTIONS
-
EventVITAFOODS EUROPE 2026
-
NewNext-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show pro...
The CIBER Cancer Area (CIBERONC) is developing advanced cellular therapies targeting pediatric sarcomas, with a special focus on Ewing sarcoma.
-
Press release
Next-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show pro...
The World Health Organization recognizes over 150 different types of sarcomas, a rare disease that poses significant diagnostic and therapeutic challenges. The CIBER Cancer Area (CIBERONC) is
-
New#NewAseBioMember | "AseBio is a key player in Spain's biotech ecosystem"
Meet our new member Inbistra. We spoke with Ignacio Sancho-Martinez CEO y co-fundadorr
-
CompanyPHARMABIOS INNOVA
-
New#NewAseBioAlly | "AseBio is a key reference point in Spain’s biotechnology ecosystem"
Meet IMCD, our new Ally. We spoke with Lander Elkoro, Market Manager Formulation & Biopharma Iberia.
-
NewName change from Leadartis and launch of new website
Trimerbody Pharma, a clinical-stage biopharmaceutical company developing proprietary therapeutic antibodies called Trimerbodies against cancer, announces that it has changed its name from Leadartis
-
NewADmit Therapeutics Relocates to New State-of-the-Art Facilities Within the Almirall’s Inn...
Biotech company ADmit Therapeutics has announced its move to new state-of-the-art facilities at “The Hive”, Almirall’s innovation hub in Sant Feliu de Llobregat. This strategic relocation strengthens
-
-
NewHow to Secure the EIC Transition Grant: 6 Key Lessons from a Spanish Success Story
The biotechnology company Viva In Vitro Diagnostics shares its experience during the CDTI and FECYT workshop, offering insight into accessing one of the EU’s most competitive programmes for disruptive
